AGP Executive Report
Last update: 8 hours agoReproductive Care: Maryland advocates warn new federal Title X funding rules could force Planned Parenthood to change services or turn away patients; applications for the next grant cycle are due Jan. 11. Drug Costs: Gov. Wes Moore and lawmakers are backing a proposal to cap prices for 25 prescription drugs, tying them to federally negotiated rates. Medicaid Access: Maryland now projects 152,000 residents could lose coverage by 2028 as work requirements and six-month renewals take effect. Rural Workforce: The state announced $16.4 million in awards to strengthen rural health care staffing. Screening: Maryland’s new mammogram disclosure requirement flags breast arterial calcification, a finding linked to heart disease. Medication Safety: A Maryland man says he became legally blind after taking Ozempic; the reported link to his vision loss has not been established. Bay Health: The Chesapeake Bay earned a C-plus, its best score in 20 years, though some measures of water clarity and harmful algae worsened.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
